Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01408485 · ClinicalTrials.gov registry record · NA

Therapy™ Cool Flex™ Irrigated Ablation System for Typical Atrial Flutter

A NA study, sponsored by Abbott Medical Devices.

Completed
Registry status
NA
Development phase
200
Enrollment target

NCT01408485: Completed NA study, sponsored by Abbott Medical Devices.

NCT01408485 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01408485, a NA study, has completed, sponsored by Abbott Medical Devices.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target

Study Summary

To demonstrate that ablation with the Therapy™ Cool Flex™ Irrigated Ablation System is effective in the treatment of typical atrial flutter (cavo-tricuspid dependent) and that its use does not result in an unacceptable risk of intra-procedural, serious cardiac adverse events.

Primary Outcome

Primary safety is defined as the incidence of composite, serious adverse events within 7 days post-procedure, regardless of whether a determination can be made regarding device relatedness.

Interventions

  • DEVICE Therapy™ Cool Flex™ Irrigated Ablation System

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2011-11
Est. Completion 2012-10
Phase NA
Abbott Medical Devices

261 total trials

What the finished NCT01408485 record still lists

NCT01408485 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 1 intervention - of which Therapy™ Cool Flex™ Irrigated Ablation System is the first listed.

NCT01408485 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01408485 about?

NCT01408485 is a clinical study titled "Therapy™ Cool Flex™ Irrigated Ablation System for Typical Atrial Flutter". To demonstrate that ablation with the Therapy™ Cool Flex™ Irrigated Ablation System is effective in the treatment of typical atrial flutter (cavo-tricuspid dependent) and that its use does not result in an unacceptable risk of intra-procedural, serious cardiac adverse events.

What is the current status of trial NCT01408485?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2011-11. Estimated completion is 2012-10.

What interventions are being tested in trial NCT01408485?

The interventions under investigation include: Therapy™ Cool Flex™ Irrigated Ablation System (DEVICE).

Who is sponsoring clinical trial NCT01408485?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01408485's enrollment target sits among peer trials

200 506th of 2000 higher than 1,434 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01408485, the US trial registry maintained by the National Library of Medicine. NCT01408485 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.